AAAAAA

   
Results: 1-25 | 26-37 |
Results: 26-37/37
Involvement of the N-terminus of Kir6.2 in coupling to the sulphonylurea receptor
Authors: Reimann, F Tucker, SJ Proks, P Ashcroft, FM
Citation: F. Reimann et al., Involvement of the N-terminus of Kir6.2 in coupling to the sulphonylurea receptor, J PHYSL LON, 518(2), 1999, pp. 325-336
Involvement of the N-terminus of Kir6.2 in the inhibition of the K-ATP channel by ATP
Authors: Proks, P Gribble, FM Adhikari, R Ashcroft, FM
Citation: P. Proks et al., Involvement of the N-terminus of Kir6.2 in the inhibition of the K-ATP channel by ATP, J PHYSL LON, 514(1), 1999, pp. 19-25
Direct photoaffinity labeling of the Kir6.2 subunit of the ATP-sensitive K+ channel by 8-azido-ATP
Authors: Tanabe, K Tucker, SJ Matsuo, M Proks, P Ashcroft, FM Seino, S Amachi, T Ueda, K
Citation: K. Tanabe et al., Direct photoaffinity labeling of the Kir6.2 subunit of the ATP-sensitive K+ channel by 8-azido-ATP, J BIOL CHEM, 274(7), 1999, pp. 3931-3933
Mapping of the physical interaction between the intracellular domains of an inwardly rectifying potassium channel, Kir6.2
Authors: Tucker, SJ Ashcroft, FM
Citation: Sj. Tucker et Fm. Ashcroft, Mapping of the physical interaction between the intracellular domains of an inwardly rectifying potassium channel, Kir6.2, J BIOL CHEM, 274(47), 1999, pp. 33393-33397
Interaction of vanadate with the cloned beta cell K-ATP channel
Authors: Proks, P Ashfield, R Ashcroft, FM
Citation: P. Proks et al., Interaction of vanadate with the cloned beta cell K-ATP channel, J BIOL CHEM, 274(36), 1999, pp. 25393-25397
Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway
Authors: Dalle, S Smith, P Blache, P Le-Nguyen, D Le Brigand, L Bergeron, F Ashcroft, FM Bataille, D
Citation: S. Dalle et al., Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway, J BIOL CHEM, 274(16), 1999, pp. 10869-10876
NEM modification prevents high-affinity ATP binding to the first nucleotide binding fold of the sulphonylurea receptor, SUR1
Authors: Matsuo, M Tucker, SJ Ashcroft, FM Amachi, T Ueda, K
Citation: M. Matsuo et al., NEM modification prevents high-affinity ATP binding to the first nucleotide binding fold of the sulphonylurea receptor, SUR1, FEBS LETTER, 458(3), 1999, pp. 292-294
ATP-sensitive K+ channels and insulin secretion: their role in health and disease
Authors: Ashcroft, FM Gribble, FM
Citation: Fm. Ashcroft et Fm. Gribble, ATP-sensitive K+ channels and insulin secretion: their role in health and disease, DIABETOLOG, 42(8), 1999, pp. 903-919
Differential sensitivity of beta-cell and extrapancreatic K-ATP channels to gliclazide
Authors: Gribble, FM Ashcroft, FM
Citation: Fm. Gribble et Fm. Ashcroft, Differential sensitivity of beta-cell and extrapancreatic K-ATP channels to gliclazide, DIABETOLOG, 42(7), 1999, pp. 845-848
Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K-ATP channel
Authors: Ashfield, R Gribble, FM Ashcroft, SJH Ashcroft, FM
Citation: R. Ashfield et al., Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K-ATP channel, DIABETES, 48(6), 1999, pp. 1341-1347
A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland
Authors: Otonkoski, T Ammala, C Huopio, H Cote, GJ Chapman, J Cosgrove, K Ashfield, R Huang, E Komulainen, J Ashcroft, FM Dunne, MJ Kere, J Thomas, PM
Citation: T. Otonkoski et al., A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland, DIABETES, 48(2), 1999, pp. 408-415
In vitro mechanism of action on insulin release of S-22068, a new putativeantidiabetic compound
Authors: Le Brigand, L Virsolvy, A Manechez, D Godfroid, JJ Guardiola-Lemaitre, B Gribble, FM Ashcroft, FM Bataille, D
Citation: L. Le Brigand et al., In vitro mechanism of action on insulin release of S-22068, a new putativeantidiabetic compound, BR J PHARM, 128(5), 1999, pp. 1021-1026
Risultati: 1-25 | 26-37 |